User login
Dr. Harold J. Wanebo reports that a neoadjuvant regimen of cetuximab and chemoradiation was linked to significant downstaging of locally advanced esophageal cancer. Bob Finn of Elsevier Global Medical News (EGMN) reports from a meeting on gastrointestinal cancer sponsored by the American Society of Clinical Oncology.
Dr. Harold J. Wanebo reports that a neoadjuvant regimen of cetuximab and chemoradiation was linked to significant downstaging of locally advanced esophageal cancer. Bob Finn of Elsevier Global Medical News (EGMN) reports from a meeting on gastrointestinal cancer sponsored by the American Society of Clinical Oncology.
Dr. Harold J. Wanebo reports that a neoadjuvant regimen of cetuximab and chemoradiation was linked to significant downstaging of locally advanced esophageal cancer. Bob Finn of Elsevier Global Medical News (EGMN) reports from a meeting on gastrointestinal cancer sponsored by the American Society of Clinical Oncology.